Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Peter Ballard, Patrick Brassil, Khanh H. Bui, Hugues Dolgos, Carl Petersson, Anders Tunek & Peter J. H. Webborn. (2012) The right compound in the right assay at the right time: an integrated discovery DMPK strategy. Drug Metabolism Reviews 44:3, pages 224-252.
Read now
Read now
Helen E. Cubitt, Karen R. Yeo, Eleanor M. Howgate, Amin Rostami-Hodjegan & Zoe E. Barter. (2011) Sources of interindividual variability in IVIVE of clearance: an investigation into the prediction of benzodiazepine clearance using a mechanistic population-based pharmacokinetic model. Xenobiotica 41:8, pages 623-638.
Read now
Read now
Joanne A. Foster, J. Brian Houston & David Hallifax. (2011) Comparison of intrinsic clearances in human liver microsomes and suspended hepatocytes from the same donor livers: clearance-dependent relationship and implications for prediction of in vivo clearance. Xenobiotica 41:2, pages 124-136.
Read now
Read now
N. Araki, S. Tsuruoka, N. Wang, G. Hasegawa, H. Yanagihara, H. Ando, T. Omasa, S. Enosawa, H. Nagai & A. Fujimura. (2008) Human CYP3A4-introduced HepG2 cells: screening system of new chemicals for the evaluation of CYP3A4-inhibiting activity. Xenobiotica 38:11, pages 1355-1364.
Read now
Read now
D. Hallifax, A. Galetin & J. B. Houston. (2008) Prediction of metabolic clearance using fresh human hepatocytes: Comparison with cryopreserved hepatocytes and hepatic microsomes for five benzodiazepines. Xenobiotica 38:4, pages 353-367.
Read now
Read now
Stefan S De Buck & Claire E Mackie. (2007) Physiologically based approaches towards the prediction of pharmacokinetics: in vitro–in vivo extrapolation. Expert Opinion on Drug Metabolism & Toxicology 3:6, pages 865-878.
Read now
Read now
Articles from other publishers (33)
Paul M. Burkat. (2023) Physiologically based pharmacokinetic and pharmacodynamic modelling of alprazolam: Implications for anxiety and addiction. British Journal of Clinical Pharmacology 89:8, pages 2569-2581.
Crossref
Crossref
P.M. Burkat. (2022) Physiologically Based Pharmacokinetic and Pharmacodynamic Modeling of Diazepam: Unbound Interstitial Brain Concentrations Correspond to Clinical End Points. The Journal of Clinical Pharmacology 62:10, pages 1297-1309.
Crossref
Crossref
Masahiro Yahata, Yuji Ishii, Tetsuya Nakagawa, Takao Watanabe & Kiyoko Bando. (2019) Species differences in metabolism of a new antiepileptic drug candidate, DSP‐0565 [2‐(2′‐fluoro[1,1′‐biphenyl]‐2‐yl)acetamide]. Biopharmaceutics & Drug Disposition 40:5-6, pages 165-175.
Crossref
Crossref
Carolina Noble, Niels Bjerre Holm, Marie Mardal & Kristian Linnet. (2018) Bromo-dragonfly, a psychoactive benzodifuran, is resistant to hepatic metabolism and potently inhibits monoamine oxidase A. Toxicology Letters 295, pages 397-407.
Crossref
Crossref
Tom De Bruyn, Ayşe Ufuk, Carina Cantrill, Rachel E. Kosa, Yi-an Bi, Mark Niosi, Sweta Modi, A. David Rodrigues, Larry M. Tremaine, Manthena V. S. Varma, Aleksandra Galetin & J. Brian Houston. (2018) Predicting Human Clearance of Organic Anion Transporting Polypeptide Substrates Using Cynomolgus Monkey: In Vitro–In Vivo Scaling of Hepatic Uptake Clearance. Drug Metabolism and Disposition 46:7, pages 989-1000.
Crossref
Crossref
Carolina Noble, Marie Mardal, Niels Bjerre Holm, Sys Stybe Johansen & Kristian Linnet. (2017)
In vitro
studies on flubromazolam metabolism and detection of its metabolites in authentic forensic samples
. Drug Testing and Analysis 9:8, pages 1182-1191.
Crossref
Crossref
Silvia Caddeo, Monica Boffito & Susanna Sartori. (2017) Tissue Engineering Approaches in the Design of Healthy and Pathological In Vitro Tissue Models. Frontiers in Bioengineering and Biotechnology 5.
Crossref
Crossref
Kenneth H. Grime, Patrick Barton & Dermot F. McGinnity. (2013) Application of In Silico, In Vitro and Preclinical Pharmacokinetic Data for the Effective and Efficient Prediction of Human Pharmacokinetics. Molecular Pharmaceutics 10:4, pages 1191-1206.
Crossref
Crossref
Masaya Sakamoto, Tomoo Itoh & Ryoichi Fujiwara. (2013) Prediction of <i>in Vivo</i> Carbamazepine 10,11-Epoxidation from <i>in Vitro</i> Metabolic Studies with Human Liver Microsomes: Importance of Its Sigmoidal Kinetics. Biological and Pharmaceutical Bulletin 36:12, pages 1959-1963.
Crossref
Crossref
P Ballard, P Brassil, K H Bui, H Dolgos, C Petersson, A Tunek & P J H Webborn. 2013. Drug Discovery and Development. Drug Discovery and Development
135
155
.
Yoshihisa Shitara, Kazuya Maeda, Kazuaki Ikejiri, Kenta Yoshida, Toshiharu Horie & Yuichi Sugiyama. (2013) Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption. Biopharmaceutics & Drug Disposition 34:1, pages 45-78.
Crossref
Crossref
R M Franke, C S Lancaster, C J Peer, A A Gibson, A M Kosloske, S J Orwick, R H Mathijssen, W D Figg, S D Baker & A Sparreboom. (2011) Effect of ABCC2 (MRP2) Transport Function on Erythromycin Metabolism. Clinical Pharmacology & Therapeutics 89:5, pages 693-701.
Crossref
Crossref
Sekihiro Tamaki, Hiroshi Komura, Motohiro Kogayu & Shizuo Yamada. (2011) Comparative Assessment of Empirical and Physiological Approaches on Predicting Human Clearances. Journal of Pharmaceutical Sciences 100:3, pages 1147-1155.
Crossref
Crossref
Vikash Sinha & Holly H. C. Kimko. 2011. Clinical Trial Simulations. Clinical Trial Simulations
483
499
.
Hayley S. Brown, Alison J. Wilby, Jane Alder & J. Brian Houston. (2010) Comparative Use of Isolated Hepatocytes and Hepatic Microsomes for Cytochrome P450 Inhibition Studies: Transporter-Enzyme Interplay. Drug Metabolism and Disposition 38:12, pages 2139-2146.
Crossref
Crossref
M. Teresa Donato, David Hallifax, Laura Picazo, José V. Castell, J. Brian Houston, M. José Gomez-Lechón & Agustin Lahoz. (2010) Metabolite Formation Kinetics and Intrinsic Clearance of Phenacetin, Tolbutamide, Alprazolam, and Midazolam in Adenoviral Cytochrome P450-Transfected HepG2 Cells and Comparison with Hepatocytes and In Vivo. Drug Metabolism and Disposition 38:9, pages 1449-1455.
Crossref
Crossref
Motohiro Kato, Koji Chiba, Takashi Ito, Toshiko Koue & Yuichi Sugiyama. (2010) Prediction of Interindividual Variability in Pharmacokinetics for CYP3A4 Substrates in Humans. Drug Metabolism and Pharmacokinetics 25:4, pages 367-378.
Crossref
Crossref
Frederique Fenneteau, Patrick Poulin & Fahima Nekka. (2010) Physiologically Based Predictions of the Impact of Inhibition of Intestinal and Hepatic Metabolism on Human Pharmacokinetics of CYP3A Substrates. Journal of Pharmaceutical Sciences 99:1, pages 486-514.
Crossref
Crossref
Suzanne C. Bell, Melissa Gayton-Ely & Corey M. Nida. (2009) Bioassays for bomb-makers: proof of concept. Analytical and Bioanalytical Chemistry 395:2, pages 401-409.
Crossref
Crossref
Masato Chiba, Yasuyuki Ishii & Yuichi Sugiyama. (2009) Prediction of Hepatic Clearance in Human From In Vitro Data for Successful Drug Development. The AAPS Journal 11:2.
Crossref
Crossref
Helen E. Cubitt, J. Brian Houston & Aleksandra Galetin. (2009) Relative Importance of Intestinal and Hepatic Glucuronidation—Impact on the Prediction of Drug Clearance. Pharmaceutical Research 26:5, pages 1073-1083.
Crossref
Crossref
Xing Han, Diane L. Nabb, Ching‐Hui Yang, Suzanne I. Snajdr & Robert T. Mingoia. (2009)
Liver microsomes and S9 from rainbow trout (
Oncorhynchus mykiss
): Comparison of basal‐level enzyme activities with rat and determination of xenobiotic intrinsic clearance in support of bioaccumulation assessment
. Environmental Toxicology and Chemistry 28:3, pages 481-488.
Crossref
Crossref
Hege Christensen, Liv Mathiesen, Lillian W. Postvoll, Bjørn Winther & Espen Molden. (2009) Different Enzyme Kinetics of Midazolam in Recombinant CYP3A4 Microsomes from Human and Insect Sources. Drug Metabolism and Pharmacokinetics 24:3, pages 261-268.
Crossref
Crossref
Peter J. Kilford, Rowan Stringer, Bindi Sohal, J. Brian Houston & Aleksandra Galetin. (2009) Prediction of Drug Clearance by Glucuronidation from in Vitro Data: Use of Combined Cytochrome P450 and UDP-Glucuronosyltransferase Cofactors in Alamethicin-Activated Human Liver Microsomes. Drug Metabolism and Disposition 37:1, pages 82-89.
Crossref
Crossref
Alison J. Parker & J. Brian Houston. (2008) Rate-Limiting Steps in Hepatic Drug Clearance: Comparison of Hepatocellular Uptake and Metabolism with Microsomal Metabolism of Saquinavir, Nelfinavir, and Ritonavir. Drug Metabolism and Disposition 36:7, pages 1375-1384.
Crossref
Crossref
John C. Lipscomb & Torka S. Poet. (2008) In vitro measurements of metabolism for application in pharmacokinetic modeling. Pharmacology & Therapeutics 118:1, pages 82-103.
Crossref
Crossref
Michael Gertz, Peter J. Kilford, J. Brian Houston & Aleksandra Galetin. (2008) Drug Lipophilicity and Microsomal Protein Concentration as Determinants in the Prediction of the Fraction Unbound in Microsomal Incubations. Drug Metabolism and Disposition 36:3, pages 535-542.
Crossref
Crossref
Matthew G. Soars, Dermot F. McGinnity, Ken Grime & Robert J. Riley. (2007) The pivotal role of hepatocytes in drug discovery. Chemico-Biological Interactions 168:1, pages 2-15.
Crossref
Crossref
Trudy Rodgers & Malcolm Rowland. (2007) Mechanistic Approaches to Volume of Distribution Predictions: Understanding the Processes. Pharmaceutical Research 24:5, pages 918-933.
Crossref
Crossref
Hayley S. Brown, Michael Griffin & J. Brian Houston. (2007) Evaluation of Cryopreserved Human Hepatocytes as an Alternative in Vitro System to Microsomes for the Prediction of Metabolic Clearance. Drug Metabolism and Disposition 35:2, pages 293-301.
Crossref
Crossref
Bernard Testa & Stefanie D. Krämer. (2006) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 3:10, pages 1053-1101.
Crossref
Crossref
Aleksandra Galetin & J. Brian Houston. (2006) Intestinal and Hepatic Metabolic Activity of Five Cytochrome P450 Enzymes: Impact on Prediction of First-Pass Metabolism. Journal of Pharmacology and Experimental Therapeutics 318:3, pages 1220-1229.
Crossref
Crossref
Nancy Hakooz, Kiyomi Ito, Helen Rawden, Helen Gill, Lynn Lemmers, Alan R. Boobis, Robert J. Edwards, David J. Carlile, Brian G. Lake & J. Brian Houston. (2006) Determination of a Human Hepatic Microsomal Scaling Factor for Predicting in Vivo Drug Clearance. Pharmaceutical Research 23:3, pages 533-539.
Crossref
Crossref